HLB Life Science Co Ltd
KOSDAQ:067630
HLB Life Science Co Ltd
Cash from Financing Activities
HLB Life Science Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Cash from Financing Activities
₩63.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Cash from Financing Activities
-₩4.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
Cash from Financing Activities
-₩110B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Cash from Financing Activities
-₩15.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Cash from Financing Activities
-₩5.3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-6%
|
See Also
What is HLB Life Science Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
63.5B
KRW
Based on the financial report for Mar 31, 2024, HLB Life Science Co Ltd's Cash from Financing Activities amounts to 63.5B KRW.
What is HLB Life Science Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-5%
Over the last year, the Cash from Financing Activities growth was -38%.